| Consolidated statement of changes in equity for the year ended December 31, 2025 | | | | | | | | | |
| Dec. 31, 2025 | Issued and paid-up capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-controlling interests | Total |
| | | | | | | | | | | | | | | |
| Beginning balance | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | - | (670,972) | 22,818 | (7,789,896) | 17,924 | 51,590,097 | 1,868,235 | 1,137,720 | 146,789,878 | 183,044 | 146,972,922 |
| Total comprehensive income net of tax: | | | | | | | | | | | | | | | |
| Net profit of the year | - | - | - | - | - | - | - | - | - | 75,460,219 | - | - | 75,460,219 | 19,963 | 75,480,182 |
| Transferred to general risk reserve | - | - | - | 26,186 | - | - | - | - | - | (26,186) | - | - | - | - | - |
| Net unrealised gain/(loss) on financial assets at fair value through OCI | - | - | - | - | - | - | - | 9,937,984 | - | - | - | - | 9,937,984 | 113,897 | 10,051,881 |
| Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | - | (2,628) | 2,628 | - | - | - | - | - |
| Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | - | (40,145) | - | - | - | - | (40,145) | - | (40,145) |
| Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | (295,691) | (295,691) | - | (295,691) |
| Total comprehensive income | - | - | - | 26,186 | - | - | - | 9,897,839 | (2,628) | 75,436,661 | - | (295,691) | 85,062,367 | 133,860 | 85,196,227 |
| Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI | - | - | - | - | - | - | - | (111,370) | - | 111,370 | - | - | - | - | - |
| Transferred to reserves | - | 2,771,284 | 19,758,610 | - | - | - | 2,246 | - | - | (21,744,828) | (787,312) | - | - | - | - |
| Transferred from net profit to special reserve | - | - | - | - | 13,145,012 | - | - | - | - | (13,145,012) | - | - | - | - | - |
| Dividend paid | - | - | - | - | - | - | - | - | - | (8,993,602) | - | - | (8,993,602) | (289,028) | (9,282,630) |
| Cost of employee's stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | - | 1,262,609 | - | 1,262,609 | - | 1,262,609 |
| Capital increase | 3,347,781 | - | (3,070,851) | - | - | - | - | - | - | - | - | - | 276,930 | - | 276,930 |
| Balance at the end of the year | 33,779,361 | 8,979,958 | 79,110,551 | 1,577,092 | 13,145,012 | (670,972) | 25,064 | 1,996,573 | 15,296 | 83,254,686 | 2,343,532 | 842,029 | 224,398,182 | 27,876 | 224,426,058 |
| | | | | | | | | | | | | | | |
| Consolidated statement of changes in equity for the year ended December 31, 2024 | | | | | | | | | |
| Dec. 31, 2024 | Issued and paid-up capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-controlling interests | Total |
| | | | | | | | | | | | | | | |
| Beginning balance | 30,195,010 | 4,770,354 | 39,840,707 | 1,550,906 | - | (670,972) | 21,155 | (17,313,043) | 15,230 | 27,442,585 | 1,486,010 | 148,353 | 87,486,295 | 160,073 | 87,646,368 |
| Total comprehensive income net of tax: | | | | | | | | | | | | | | | |
| Net profit of the year | - | - | - | - | - | - | - | - | - | 49,558,744 | - | - | 49,558,744 | 60,338 | 49,619,082 |
| Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI | - | - | - | - | - | - | - | (370,224) | - | - | - | - | (370,224) | - | (370,224) |
| Net unrealised gain/(loss) on financial assets at fair value through OCI | - | - | - | - | - | - | - | 8,956,422 | - | - | - | - | 8,956,422 | - | 8,956,422 |
| Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | - | 2,694 | (2,694) | - | - | - | - | - |
| Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | - | 936,949 | - | - | - | - | 936,949 | - | 936,949 |
| Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | 989,367 | 989,367 | - | 989,367 |
| Total comprehensive income | - | - | - | - | - | - | - | 9,523,147 | 2,694 | 49,556,050 | - | 989,367 | 60,071,258 | 60,338 | 60,131,596 |
| Transfer of investment revaluation reserve upon disposal of investments in equity instruments designated as at FVTOCI | - | - | - | - | - | - | - | - | - | 370,224 | - | - | 370,224 | - | 370,224 |
| Transferred to reserves | - | 1,438,320 | 22,582,085 | - | - | - | 1,663 | - | - | (23,398,943) | (623,125) | - | - | - | - |
| Dividend paid | - | - | - | - | - | - | - | - | - | (2,379,819) | - | - | (2,379,819) | (37,367) | (2,417,186) |
| Cost of employee's stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | - | 1,005,350 | - | 1,005,350 | - | 1,005,350 |
| Capital increase | 236,570 | - | - | - | - | - | - | - | - | - | - | - | 236,570 | - | 236,570 |
| Balance at the end of the year | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | - | (670,972) | 22,818 | (7,789,896) | 17,924 | 51,590,097 | 1,868,235 | 1,137,720 | 146,789,878 | 183,044 | 146,972,922 |
| | | | | | | | | | | | | | | |
| Consolidated Statement of Cash Flow for the Year Ended December 31, 2025 | |
| | | | | |
| Notes | Dec. 31, 2025 | | Dec. 31, 2024 | |
| | | | |
| | | | | |
| Cash flow from operating activities | | | | | |
| Profit before income tax | | 104,803,388 | | 71,498,028 | |
| Adjustments to reconcile profits to net cash provided by operating activities | | | | | |
| Fixed assets depreciation | | 2,307,297 | | 1,414,920 | |
| Impairment charge for credit losses (Loans and advances to customers) | | (9,101,206) | | 4,768,107 | |
| Net charge/release for other provisions | | (2,893,591) | | 3,363,525 | |
| Impairment release/charge for credit losses (due from banks) | | 137,399 | | (341) | |
| Impairment release/charge for credit losses (financial investments) | | 146,649 | | (243,947) | |
| Impairment release/charge for other assets | | - | | 37,939 | |
| Exchange revaluation differences for financial assets at fair value through OCI and AC | | 5,137,808 | | (21,026,044) | |
| Utilization of other provisions | | (7,467) | | (9,586) | |
| Revaluation differences impairment charge for due from banks | | (8,542) | | 2,008 | |
| Exchange revaluation differences of other provisions | | (77,925) | | 4,173,699 | |
| Revaluation differences impairment charge for Financial Assets at Amortized cost | | (18,527) | | 119,504 | |
| Profits from selling property, plant and equipment | | (13,005) | | (2,246) | |
| Profits/losses from selling financial investments at fair value through OCI | | (498,433) | | (459,337) | |
| Revaluation differences impairment charge for Financial Assets at Fair value through OCI | | (242,624) | | 1,329,905 | |
| Shares based payments | | 1,262,609 | | 1,005,350 | |
| Profits/losses from selling investments in associates | | (277,408) | | - | |
| Net share of results of associates | | (10,512) | | 17,786 | |
| | 100,645,910 | | 65,989,270 | |
| | | | | |
| Change in: | | | | | |
| Due from banks | | 98,091,341 | | (111,192,809) | |
| Financial assets at fair value through profit or loss | | (2,792,770) | | (74,394) | |
| Derivative financial instruments | | (88,654) | | 490,593 | |
| Loans and advances to banks and customers | | (180,420,385) | | (122,049,597) | |
| Other assets | | (5,289,420) | | (22,078,200) | |
| Non-current assets held for sale | | (182,827) | | - | |
| Non-current liabilities held for sale | | 52,463 | | 524 | |
| Due to banks | | 1,318,861 | | (10,423,118) | |
| Due to customers | | 137,799,735 | | 295,358,479 | |
| Current income tax obligations paid | | (27,080,861) | | (5,220,965) | |
| Other liabilities | | 7,489,703 | | 5,788,117 | |
| Net cash generated from operating activities | | 129,543,096 | | 96,587,900 | |
| | | | | |
| | | | | |
| | | | | |
| Cash flow from investing activities | | | | | |
| Proceeds from sale of investments in associates | | 339,920 | | 11,956 | |
| Payments for purchases of property, equipment and branches construction | | (7,930,273) | | (6,707,018) | |
| Proceeds from selling property and equipment | | 13,005 | | 2,246 | |
| Proceeds from redemption of financial assets at amortized cost | | 21,689,390 | | 2,028,180 | |
| Payments for purchases of financial assets at amortized cost | | (90,488,312) | | (129,153,136) | |
| Payments for purchases of financial assets at fair value through OCI | | (263,771,830) | | (113,445,585) | |
| Proceeds from selling financial assets at fair value through OCI | | 127,867,188 | | 140,381,225 | |
| Net cash generated from (used in) investing activities | | (212,280,912) | | (106,882,132) | |
| | | | | |
| |
| Consolidated Statement of Cash Flow for the Year Ended December 31, 2025 (Cont.) | |
| | | | | |
| Notes | Dec. 31, 2025 | | Dec. 31, 2024 | |
| | | | |
| | | | | |
| Cash flow from financing activities | | | | | |
| Other loans | | 6,509,110 | | 11,478,482 | |
| Other loans - new loans obtained in the year | | 8,701,546 | | 3,835,016 | |
| Other loans - loans repaid in the year | | (789,099) | | (243,015) | |
| Other loans - movement in foreign exchange rate | | (1,403,337) | | 7,886,481 | |
| Dividends | | (9,282,630) | | (2,379,819) | |
| Issued debt instruments | | (306,223) | | 1,994,432 | |
| Cash payments for lease (principal and interest) | | (391,907) | | (501,724) | |
| Capital increase | | 276,930 | | 236,570 | |
| Net cash generated from (used in) financing activities | | (3,194,720) | | 10,827,941 | |
| | | | | |
| | | | | |
| Net increase (decrease) in cash and cash equivalent during the year | | (85,932,536) | | 533,709 | |
| Beginning balance of cash and cash equivalent | | 226,475,092 | | 225,941,383 | |
| Cash and cash equivalent at the end of the year | | 140,542,556 | | 226,475,092 | |
| | | | | |
| Cash and cash equivalent at the end of the year | | | | | |
| Cash and cash equivalents | 13 | 20,002,406 | | 21,752,997 | |
| Due from banks with maturities of 3 months or less | 15 | 120,525,563 | | 203,103,430 | |
| Treasury bills and other governmental notes with maturities of three months or less | | 14,587 | | 1,618,665 | |
| Total cash and cash equivalent | 32 | 140,542,556 | | 226,475,092 | |
| | | | | |
| | | | | |
| | | | | |
| | | | | | | | | | | | | | | | | | | |